OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
|Articles|January 1, 2004
- Volume 0 0
GER Is Common Among Children with Bronchial Asthma
Advertisement
Gastroesophageal reflux (GER) is highly prevalent in children with bronchial asthma, according to a presentation made at the annual meeting of the American College of Allergy, Asthma & Immunology on November 10, 2003, in New Orleans, La.
Results of the study, conducted by Mittal et al, indicate that prevalence of GER increases with severity of asthma. When bronchial asthma was stratified by severity, the prevalence of GER was 0% in mild intermittent asthma, 11% in mild persistent asthma, 23% in moderate persistent asthma, and 57% in severe persistent asthma.
Only 47% of children with GER had 1 or more symptoms of reflux, indicating that many children with GER are asymptomatic. For more information, visit www.medscape. com/viewarticle/464202.
Articles in this issue
almost 23 years ago
Not All GERD Patients Are Alikealmost 23 years ago
Chronic Constipation Makes Headlinesalmost 23 years ago
Dyspepsia and Gastric Emptying in Diabeticsalmost 23 years ago
New Indications: 2003almost 23 years ago
Can You Read These Rxs? Answersalmost 23 years ago
Compounding Hotlinealmost 23 years ago
Sleep Apnea Is Tied to Depression?almost 23 years ago
Women Are Shortchanged on Getting Shut-Eyealmost 23 years ago
RLS Runs in the Familyalmost 23 years ago
Case Studies AnswersAdvertisement
Related to this article
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Payer requirements, prescriber habits, and operational realities ultimately determine which ICI patients receive.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
3
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
4
The Most Accessible Healthcare Professional—But Accessible to Whom?
5